Loading...

World-Class Retina Care. Community-Based Caring.

Dr. Abbey Presents Phase 1 DAVIO Clinical Trial Results to the Association for Research in Vision and Ophthalmology

Posted On May 31, 2023 / By / Posted in Blog

Dr. Abbey Presents Phase 1 DAVIO Clinical Trial Results to the Association for Research in Vision and Ophthalmology

Dr. Abbey presented the results from the Phase 1 DAVIO trial at ARVO 2023, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO). The trial was a first-in-human

read more
Posted On May 12, 2023 / By / Posted in Blog

New Clinical Trials Available

At Texas Retina Associates, our physicians remain actively involved in conducting research that will improve care for our patients, offering access to promising new retinal treatments through clinical trials. We recently opened

read more
Posted On April 25, 2023 / By / Posted in Blog

Dr. Abbey Featured in Retina Times

Texas Retina Associates’ Ashkan Abbey, MD, was featured in the “5 Questions” segment of the latest issue of Retina Today. In the article, he discusses his passion for retina research, what led

read more
Posted On March 27, 2023 / By / Posted in Blog

Texas Retina Associates Led the Way at the 2023 VisionWalk to Benefit the Foundation Fighting Blindness

This past Saturday, Texas Retina Associates sponsored and participated in the 2023 Dallas-Fort Worth VisionWalk to benefit the Foundation Fighting Blindness and was recognized as the “Largest Team.” Our “Walk Stars” came

read more
Posted On February 28, 2023 / By / Posted in Blog

Four New Clinical Trials Available at Texas Retina Associates

Our physicians remain committed to participating in ongoing retina research and providing our patients access to promising new treatment options through clinical trials. We recently opened four new clinical trials: Diabetic Macular

read more
Posted On June 20, 2022 / By / Posted in Blog

Texas Retina Associates Announces the Retirement of David Callanan, MD

It is with mixed emotions that we announce the retirement of David Callanan, MD, from Texas Retina Associates effective June 30, 2022. He has been caring for patients at our practice since

read more
Posted On April 19, 2022 / By / Posted in Blog

Dr. Abbey Spoke About Complications of a Compounded Medication Used in “Dropless” Cataract Surgery at the Vit-Buckle Society (VBS) Annual Meeting

Texas Retina Associates’ Ashkan M. Abbey, MD, presented “Complications of Compounded Moxifloxacin-Triamcinolone” at the 10th Annual Meeting of the Vit-Buckle Society (VBS) held March 24 – 26, 2022, in Las Vegas. He

read more
Posted On October 19, 2021 / By / Posted in Blog

Dr. Abbey to Speak at Upcoming Retina World Congress Medical Education Event

On October 24, 2021, Texas Retina Associates’ Ashkan M. Abbey, MD, will serve on a distinguished panel of presenters from across the country for a Retina World Congress continuing medical education (CME)

read more
Posted On December 12, 2019 / By / Posted in Blog

Ashkan Abbey, MD, Publishes Article Summarizing Highlights from American Academy of Ophthalmology Retina 2019 Subspecialty Day

Texas Retina Associates’ Ashkan Abbey, MD, recently published an article in the current issue of Retina Specialist that summarized the findings of five compelling clinical trial presentations from the American Academy of

read more
Posted On November 8, 2019 / By / Posted in Blog

David Callanan, MD, Presented Uveitis Clinical Trial Results at American Society of Retina Specialists 2019 Annual Meeting

Texas Retina Associates’ David Callanan, MD, presented the results of a clinical trial on a promising new treatment for chronic posterior segment uveitis at the American Society of Retina Specialists (ASRS) 2019

read more